September 28. 2007

• Once-daily, short-course levofloxacin is at least as effective as a 10-day treatment with ciprofloxacin for the treatment of acute pyelonephritis
• Another case of torsade de pointes due to moxifloxacin

September 21. 2007

• Swiss urologists prefer a fluoroquinolne when performing a prostate biopsy
• Spanish scientists study the pulmonary delivery of levofloxacin

September 14. 2007

• Eradication rate of H. pylori improved by triple therapy involving levofloxacin
• American researchers seek ways of preventing resistance to levofloxacin in Streptococcus pneumoniae

September 10. 2007

• 1000 mg levofloxacin once-daily is an effective treatment of respiratory infections in patients with chronic lung disease
• A Turkish study shows that triple therapy with moxifloxacin produces an unacceptably low eradication of Helicobacter pylori

September 3. 2007

• Early levofloxacin therapy shown to be effective in an outbreak of Legionnaires’ disease in immunosuppressed patients
• Levofloxacin suppresses IL-6 production, suggesting a wider role for this potent antibiotic

Return to Quinolones News Index